149 related articles for article (PubMed ID: 9720722)
1. Interleukin-10 inhibits the in vitro proliferation of human activated leukemic CD5+ B-cells.
Tangye SG; Weston KM; Raison RL
Leuk Lymphoma; 1998 Sep; 31(1-2):121-30. PubMed ID: 9720722
[TBL] [Abstract][Full Text] [Related]
2. Cytokines and cross-linking of sIgM augment PMA-induced activation of human leukaemic CD5+ B cells.
Tangye SG; Weston KM; Raison RL
Immunol Cell Biol; 1997 Dec; 75(6):561-7. PubMed ID: 9492192
[TBL] [Abstract][Full Text] [Related]
3. Phorbol ester activates CD5+ leukaemic B cells via a T cell-independent mechanism.
Tangye SG; Weston KM; Raison RL
Immunol Cell Biol; 1995 Feb; 73(1):44-51. PubMed ID: 7539402
[TBL] [Abstract][Full Text] [Related]
4. Proliferative response of highly purified B chronic lymphocytic leukemia cells in serum free culture to interleukin-2 and tumor necrosis factors alpha and beta.
Moberts R; Hoogerbrugge H; van Agthoven T; Löwenberg B; Touw I
Leuk Res; 1989; 13(11):973-80. PubMed ID: 2481793
[TBL] [Abstract][Full Text] [Related]
5. Human interleukin 4 down-regulates the surface expression of CD5 on normal and leukemic B cells.
Defrance T; Vanbervliet B; Durand I; Banchereau J
Eur J Immunol; 1989 Feb; 19(2):293-9. PubMed ID: 2467815
[TBL] [Abstract][Full Text] [Related]
6. Human cytokines suppress apoptosis of leukaemic CD5+ B cells and preserve expression of bcl-2.
Tangye SG; Raison RL
Immunol Cell Biol; 1997 Apr; 75(2):127-35. PubMed ID: 9107564
[TBL] [Abstract][Full Text] [Related]
7. Cellular activation without proliferation to B cell growth factor and interleukin 2 in chronic lymphocytic leukaemia B cells stimulated with phorbol ester plus calcium ionophore.
Engel P; Inglés J; de la Calle O; Gallart T
Clin Exp Immunol; 1989 Apr; 76(1):61-7. PubMed ID: 2500274
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-4 inhibits both paracrine and autocrine tumor necrosis factor-alpha-induced proliferation of B chronic lymphocytic leukemia cells.
van Kooten C; Rensink I; Aarden L; van Oers R
Blood; 1992 Sep; 80(5):1299-306. PubMed ID: 1381243
[TBL] [Abstract][Full Text] [Related]
9. Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells.
Schena M; Larsson LG; Gottardi D; Gaidano G; Carlsson M; Nilsson K; Caligaris-Cappio F
Blood; 1992 Jun; 79(11):2981-9. PubMed ID: 1375120
[TBL] [Abstract][Full Text] [Related]
10. Effect of IL-4 and IL-6 on the proliferation and differentiation of B-chronic lymphocytic leukemia cells.
van Kooten C; Rensink I; Aarden L; van Oers R
Leukemia; 1993 Apr; 7(4):618-24. PubMed ID: 8464239
[TBL] [Abstract][Full Text] [Related]
11. A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.
Ghamlouch H; Ouled-Haddou H; Damaj G; Royer B; Gubler B; Marolleau JP
PLoS One; 2013; 8(3):e60370. PubMed ID: 23555960
[TBL] [Abstract][Full Text] [Related]
12. Induction of surface marker changes and monoclonal idiotypic immunoglobulin secretion in lymphoma/leukemia cells: comparative study with interleukin-1, interleukin-2, interleukin-4, 8-bromo-guanosine, pokeweed mitogen, and tetradecanoyl phorbol-13-acetate.
Gazitt Y; Gangavalli A; Thurman GB
Mol Biother; 1989; 1(6):297-304. PubMed ID: 2610949
[TBL] [Abstract][Full Text] [Related]
13. Immobilized anti-CD5 together with prolonged activation of protein kinase C induce interleukin 2-dependent T cell growth: evidence for signal transduction through CD5.
Vandenberghe P; Ceuppens JL
Eur J Immunol; 1991 Feb; 21(2):251-9. PubMed ID: 1705509
[TBL] [Abstract][Full Text] [Related]
14. IFN-alpha stimulates proliferation and cytokine secretion of CD40-stimulated B cell chronic lymphocytic leukemia cells in vitro.
Brass U; Tretter T; Schneller F; Schuler M; Huber C; Peschel C
J Interferon Cytokine Res; 1999 Apr; 19(4):335-43. PubMed ID: 10334384
[TBL] [Abstract][Full Text] [Related]
15. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of CD5 mRNA in B-chronic lymphocytic leukemia cells by differentiation-inducing agents.
Gignac SM; Buschle M; Hoffbrand AV; Drexler HG
Eur J Immunol; 1990 May; 20(5):1119-23. PubMed ID: 1694132
[TBL] [Abstract][Full Text] [Related]
17. Expression and production of cytokines by heterohybrids and their parental B cells in CLL.
Diaw L; Lefebvre d'Hellencourt C; Cornillet I; Vuillier F; Guenounou M; Dighiero G
Leuk Lymphoma; 1996 Apr; 21(3-4):281-91. PubMed ID: 8726409
[TBL] [Abstract][Full Text] [Related]
18. Cytokine modulation of nuclear factor-kappaB activity in B-chronic lymphocytic leukemia.
Zaninoni A; Imperiali FG; Pasquini C; Zanella A; Barcellini W
Exp Hematol; 2003 Mar; 31(3):185-90. PubMed ID: 12644014
[TBL] [Abstract][Full Text] [Related]
19. Proliferation and differentiation of human CD5+ and CD5- B cell subsets activated through their antigen receptors or CD40 antigens.
Defrance T; Vanbervliet B; Durand I; Briolay J; Banchereau J
Eur J Immunol; 1992 Nov; 22(11):2831-9. PubMed ID: 1385152
[TBL] [Abstract][Full Text] [Related]
20. The response of human B cells to interleukin 4 is determined by their stage of activation and differentiation.
Maher DW; Pike BL; Boyd AW
Scand J Immunol; 1990 Dec; 32(6):631-40. PubMed ID: 1702898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]